BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31520466)

  • 1. Role of a novel circulatory RNA-based biomarker panel expression in ovarian cancer.
    El-Shal AS; Matboli M; Abdelaziz AM; Morsy AA; Abdelbary EH
    IUBMB Life; 2019 Dec; 71(12):2031-2047. PubMed ID: 31520466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-coding RNA MIAT Mediates Non-small Cell Lung Cancer Development Through Regulating the miR-128-3p/PELI3 Axis.
    Li F; Li H; Li S; Lv B; Shi J; Yan H; Zhang H; He Y
    Biochem Genet; 2020 Dec; 58(6):867-882. PubMed ID: 32556677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-29c-3p, a target miRNA of LINC01296, accelerates tumor malignancy: therapeutic potential of a LINC01296/miR-29c-3p axis in ovarian cancer.
    Xu H; Mao HL; Zhao XR; Li Y; Liu PS
    J Ovarian Res; 2020 Mar; 13(1):31. PubMed ID: 32192508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
    Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
    Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA PCAT-1 knockdown prevents the development of ovarian cancer cells via microRNA-124-3p.
    Min F; Chu G
    J Cell Biochem; 2020 Feb; 121(2):1963-1972. PubMed ID: 31674073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis.
    Liu N; Zhou Q; Qi YH; Wang H; Yang L; Fan QY
    Exp Mol Pathol; 2017 Aug; 103(1):71-77. PubMed ID: 28655518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated LINC00909 Promotes Tumor Progression of Ovarian Cancer via Regulating the miR-23b-3p/MRC2 Axis.
    Yang X; Wu G; Yang F; He L; Xie X; Li L; Yang L; Ma Y; Zhang Q; Chen J; Zou S; Han Q; Wang Y; Liu S; Li J; Han B; Liu K
    Oxid Med Cell Longev; 2021; 2021():5574130. PubMed ID: 34336102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of the long non-coding RNA SPRY4-IT1 indicates a poor prognosis and promotes tumorigenesis in ovarian cancer.
    Li H; Liu C; Lu Z; Chen L; Wang J; Li Y; Ma H
    Biomed Pharmacother; 2017 Apr; 88():529-534. PubMed ID: 28129625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical significance of lncRNA FAM83H-AS1 in ovarian cancer.
    Gong YB; Zou YF
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4656-4662. PubMed ID: 31210291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
    Li W; Ma S; Bai X; Pan W; Ai L; Tan W
    J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum exosomal miR-484 expression predicts unfavorable prognosis in ovarian cancer.
    Zhang W; Su X; Li S; Liu Z; Wang Q; Zeng H
    Cancer Biomark; 2020; 27(4):485-491. PubMed ID: 32065786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of lncRNA-TSIX, miR-548-a-3p, and SOGA1 mRNA in the diagnosis of hepatocellular carcinoma.
    Habieb A; Matboli M; El-Tayeb H; El-Asmar F
    Mol Biol Rep; 2019 Aug; 46(4):4581-4590. PubMed ID: 31004302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA GIHCG promotes development of ovarian cancer by regulating microRNA-429.
    Yao N; Yu L; Zhu B; Gan HY; Guo BQ
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8127-8134. PubMed ID: 30556850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential biomarker of circulating hsa-miR-1273g-3p level for detection of recurrent epithelial ovarian cancer.
    Günel T; Gumusoglu E; Dogan B; Ertem FB; Hosseini MK; Cevik N; Senol T; Topuz S; Aydinli K
    Arch Gynecol Obstet; 2018 Dec; 298(6):1173-1180. PubMed ID: 30264202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance and oncogene function of long noncoding RNA HAGLROS overexpression in ovarian cancer.
    Yang M; Zhai Z; Zhang Y; Wang Y
    Arch Gynecol Obstet; 2019 Sep; 300(3):703-710. PubMed ID: 31197441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF-β receptor 1 by miR-1343-3p.
    Li Y; Zhao Z; Sun D; Li Y
    J Clin Lab Anal; 2021 Feb; 35(2):e23651. PubMed ID: 33247856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Value of Plasma-Based MicroRNAs as Diagnostic Biomarkers for Ovarian Cancer.
    Wang W; Yin Y; Shan X; Zhou X; Liu P; Cao Q; Zhu D; Zhang J; Zhu W
    Am J Med Sci; 2019 Oct; 358(4):256-267. PubMed ID: 31353030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Guan MM; Rao QX; Huang ML; Wang LJ; Lin SD; Chen Q; Liu CH
    Med Sci Monit; 2019 Oct; 25():8131-8141. PubMed ID: 31663517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer.
    Chen H; Tian X; Luan Y; Lu H
    Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.